查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088787

傷口縫合及進階創傷護理市場：依產品類型、傷口類型、臨床應用、產品易用性、最終使用者及通路分類－2026-2032年全球市場預測

Wound Closure & Advanced Wound Care Market by Product Type, Wound Type, Clinical Application, Product Usability, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，傷口縫合和進階創傷護理市場將成長至 325.1 億美元，複合年成長率為 8.04%。

主要市場統計數據
基準年 2025 189億美元
預計年份：2026年 204億美元
預測年份：2032年 325.1億美元
複合年成長率 (%) 8.04%

傷口縫合和高級創傷護理正日益成為醫療保健服務的重要環節。這主要是由於急性和慢性傷口的臨床負擔不斷加重，而這又受到外科手術量增加、創傷護理需求成長、糖尿病、肥胖症、血管疾病以及人口老化等因素的影響。此類產品包括縫合線、縫合釘、組織黏合劑、密封劑、止血劑、負壓傷口治療、抗菌敷料和泡棉敷料、親水膠體敷料、藻酸鹽敷料、膠原蛋白產品、皮膚替代物以及數位化傷口評估工具。

這項需求背後有已證實的公共衛生趨勢支撐。根據世界衛生組織（WHO）統計，到2022年，全球將有超過8億成年人患有糖尿病；聯合國預測，到2050年，全球六分之一的人口將超過65歲。國際糖尿病聯盟（IDF）也指出，糖尿病足併發症是導致糖尿病患者住院和下肢截肢的主要原因。這些趨勢導致糖尿病足潰瘍、靜脈性腿部潰瘍、壓瘡和手術部位併發症的發生率不斷上升，因此，循證傷口縫合和先進的創傷護理對於成本控制、患者預後和醫院品質至關重要。

創傷護理領域的變革性變化

傷口縫合和高級創傷護理領域正從通用傷口敷料轉向以治療效果為導向的傷口護理。臨床醫生越來越重視濕性傷口護理、滲出液控制、感染預防、組織再生、減少疤痕以及縮短傷口癒合時間。這加速了抗菌敷料、生物活性基質、可吸收封閉裝置、皮膚黏合劑、止血劑和負壓傷口治療在醫院、門診手術中心、長期照護機構和居家醫療機構的應用。

人工智慧（AI）的累積影響

人工智慧（AI）不再是遙不可及的概念，它正逐漸成為實現傷口縫合和進階創傷護理的實用手段。人工智慧驅動的影像分析能夠透過標準化照片估算傷口面積、傷口邊緣變化、組織類型、滲出模式以及癒合過程。在糖尿病足併發症的照護和壓瘡預防方面，結合合併症、運動功能、血流、營養狀況、感染指標和先前傷口史的預測模型可以支持更早的風險分層。

關鍵區域洞察

亞太地區（包括中國、印度、日本、韓國和澳洲）的戰略重要性日益凸顯，這得益於其大規模的外科手術病例數量、不斷上升的糖尿病患病率、人口老齡化以及對醫院容量的投資。此外，該地區的國家衛生系統正在擴展數位醫療、感染預防和慢性病管理項目，從而滿足了對先進傷口敷料、負壓傷口治療和遠端傷口評估的需求。北美地區憑藉高額的醫療報銷機制、龐大的傷口縫合量、完善的門診傷口護理中心、醫院品質管理計畫以及積極採用負壓傷口治療、生技藥品、抗菌敷料和數位化創傷護理工具，仍然是高品質傷口閉合和先進傷口創傷護理技術的標竿。

關鍵群體特定見解

東協市場正透過醫院現代化、醫療旅遊、中產階級就醫管道的拓展以及在地化生產而蓬勃發展，由此催生了對價格適中、性能卓越的敷料、抗菌產品、外科傷口縫合器械和感染控制解決方案的極高需求。海灣合作理事會（GCC）優先發展專業傷口診所、糖尿病護理、高品質的醫院基礎設施以及數位化醫療技術，這為負壓傷口治療、皮膚替代品、高性能止血劑和系統化的數位化傷口記錄創造了發展機會。

主要國家概況

美國在高階傷口護理技術、門診傷口護理中心、居家醫療整合以及以價值為導向的降低手術部位感染率方面一直處於主導地位。而加拿大則強調實證採購、遵循臨床指引以及各省之間公平的醫療服務取得。墨西哥和巴西的需求不斷成長，這得益於私人醫療保健的擴張、創傷護理需求的增加以及與糖尿病和血管疾病相關的慢性傷口護理需求的增加。在英國、德國、法國、義大利和西班牙，人口老化、對公共保險報銷的嚴格審查、合理使用抗生素以及在醫院、社區和長期護理機構中切實降低成本的需求，正在影響著市場格局。

為行業領導者提供的實用建議

產業領導者應優先考慮那些能夠加快治療速度、降低感染率、減少換藥次數、降低併發症風險並降低整體醫療成本的產品。臨床證據應涵蓋糖尿病足潰瘍、靜脈性下肢潰瘍、壓瘡、燒傷、手術傷口和創傷性傷口等各種情況的真實世界結果。此外，還應包括對臨床醫生、支付者和採購團隊至關重要的終點指標，例如治療時間、感染率、疼痛程度、易用性和資源利用率。

調查方法

本執行摘要基於系統的二手調查方法，使用了檢驗的公共衛生、監管、臨床和經濟資訊來源。資訊來源包括世界衛生組織、聯合國、美國疾病管制與預防中心、美國食品藥物管理局、歐盟委員會、經濟合作暨發展組織、國際糖尿病聯盟、同儕審查的創傷護理文獻、醫院品質評估框架、臨床指南以及公開的報銷和監管資訊披露。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章傷口縫合與進階創傷護理市場：依產品類型分類

  • 傳統傷口縫合裝置
    • 縫合線
    • 主食
    • 機械閉合裝置
      • 皮膚縫合膠帶
      • 拉鍊式閉合裝置
      • 傷口縫合裝置
  • 進階傷口敷料
    • 泡棉敷料
    • 水凝膠敷料
    • 膜敷料
    • 膠原蛋白敷料
    • 抗菌敷料
  • 止血劑和密封劑
  • 先進的治療方法
    • 傷口護理裝置
    • 氧氣療法系統
    • 電刺激設備
    • 超音波治療設備
  • 生技藥品及再生醫學產品
    • 皮膚替代材料
      • 異體皮膚替代品
      • 異種皮膚替代材料
      • 生物工程皮膚替代品
    • 生長因子療法
    • 細胞療法

第8章：傷口縫合和進階創傷護理市場：按傷口類型分類

  • 慢性傷口
  • 急性傷口

第9章：傷口縫合與進階創傷護理市場：依臨床應用分類

  • 外科性創傷閉合
  • 創傷性傷口管理
  • 運動傷害管理
  • 重組/整形外科
  • 燒傷傷口處理
  • 慢性潰瘍的治療

第10章：傷口縫合與進階創傷護理市場：產品用途

  • 一次使用
  • 可重複使用的

第11章傷口縫合與進階創傷護理市場：依最終使用者分類

  • 醫院
  • 門診手術中心
  • 專科診所
  • 家庭醫療保健服務提供者
  • 軍人和退伍軍人護理設施

第12章：傷口縫合與進階創傷護理市場：依通路分類

  • 離線
  • 線上

第13章：傷口縫合與進階創傷護理市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章傷口縫合與進階創傷護理市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章傷口縫合與進階創傷護理市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Solventum Corporation
  • Smith & Nephew PLC
  • Molnlycke Health Care AB
  • Baxter International Inc.
  • Johnson & Johnson Services, Inc.
  • Convatec Limited
  • Paul Hartmann AG
  • Organogenesis Inc.
  • Medtronic PLC
  • Coloplast A/S
  • Medline Industries, Inc.
  • Laboratoires Urgo
  • Essity AB
  • Integra LifeSciences Corporation
  • MiMedx Group, Inc.
  • Lohmann & Rauscher GmbH & Co. KG
  • B. Braun SE
  • Nichiban Co., Ltd.
  • Zimmer Biomet Holdings, Inc.
  • Cardinal Health, Inc.
  • PolyNovo Limited
  • Advanced Medical Solutions Group PLC
  • Avery Dennison Corporation
  • BDK Industrial Products Ltd.
  • Biogennix, LLC
  • DermaRite Industries, LLC
  • Healogics, LLC
  • Lotus Surgicals by TI Medical
  • Plastod SpA
Product Code: MRR-221461476BAB

The Wound Closure & Advanced Wound Care Market is projected to grow by USD 32.51 billion at a CAGR of 8.04% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 18.90 billion
Estimated Year [2026] USD 20.40 billion
Forecast Year [2032] USD 32.51 billion
CAGR (%) 8.04%

Wound closure and advanced wound care are converging into a high-priority segment of healthcare delivery as surgical volumes, trauma care needs, diabetes, obesity, vascular disease, and population aging expand the clinical burden of acute and chronic wounds. The category spans sutures, staples, tissue adhesives, sealants, hemostats, negative pressure wound therapy, antimicrobial and foam dressings, hydrocolloids, alginates, collagen products, skin substitutes, and digital wound assessment tools.

Demand is supported by verified public-health trends: the WHO reports that more than 800 million adults were living with diabetes in 2022, while the United Nations projects that one in six people globally will be aged 65 or older by 2050. The International Diabetes Federation also identifies diabetic foot complications as a major cause of hospitalization and lower-limb amputation among people with diabetes. These trends raise the incidence of diabetic foot ulcers, venous leg ulcers, pressure injuries, and surgical-site complications, making evidence-based wound closure and advanced wound care central to cost control, patient outcomes, and hospital quality performance.

Transformative Shifts in the Wound Care Landscape

The wound closure and advanced wound care landscape is shifting from commodity wound covering toward outcome-driven wound healing. Clinicians increasingly prioritize moist wound healing, exudate control, infection prevention, tissue regeneration, scar minimization, and reduced time to closure. This is accelerating adoption of antimicrobial dressings, bioactive matrices, absorbable closure devices, topical skin adhesives, hemostatic agents, and negative pressure wound therapy across hospitals, ambulatory surgery centers, long-term care, and home healthcare.

A second shift is the move from episodic treatment to continuum-based wound management. Payers and providers are placing greater emphasis on preventing surgical-site infections, pressure injuries, amputations, and readmissions because these complications increase length of stay and downstream costs. Regulatory expectations for clinical evidence, biocompatibility, antimicrobial stewardship, usability, and post-market surveillance are also reshaping product development and commercialization strategies.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical enabler of wound closure and advanced wound care rather than a distant concept. AI-supported imaging can help estimate wound area, wound edge change, tissue type, exudate patterns, and healing trajectory from standardized photographs. In diabetic foot care and pressure injury prevention, predictive models can support earlier risk stratification by combining comorbidities, mobility, perfusion, nutrition, infection markers, and prior wound history.

The impact is cumulative across the care pathway: better triage, more consistent documentation, remote monitoring, supply planning, clinician education, and clinical decision support. However, AI adoption must align with FDA software-as-a-medical-device principles, EU medical-device and AI requirements, data privacy rules, bias testing, cybersecurity, and clinician oversight. The strongest use cases will augment, not replace, wound specialists by improving consistency, speed, and visibility across wound healing workflows.

Key Regional Insights

Asia-Pacific is gaining strategic importance because China, India, Japan, South Korea, and Australia combine large surgical populations with rising diabetes prevalence, aging demographics, and investment in hospital capacity. National health systems across the region are also expanding digital health, infection prevention, and chronic disease management programs, which supports demand for advanced dressings, negative pressure wound therapy, and telewound assessment. North America remains a benchmark for premium wound closure and advanced wound care technologies, supported by advanced reimbursement pathways, high procedure volumes, outpatient wound care centers, hospital quality programs, and strong adoption of negative pressure wound therapy, biologics, antimicrobial dressings, and digital assessment tools.

Latin America is expanding through private hospital networks, trauma care needs, and growing access to modern dressings, although affordability, public reimbursement variability, and uneven specialist access remain constraints. Europe is shaped by Medical Device Regulation compliance, health technology assessment, antimicrobial stewardship, sustainability expectations, and demand for cost-effective healing outcomes across aging populations. The Middle East is investing in specialty care, diabetes management infrastructure, and high-acuity hospital systems, while Africa presents long-term potential tied to trauma care, infection control, burn management, surgical access, and stronger procurement systems for essential and advanced wound care products.

Key Group Insights

ASEAN markets are advancing through hospital modernization, medical tourism, expanding middle-class access, and regional manufacturing, with demand strongest for affordable advanced dressings, antimicrobial products, surgical closure devices, and infection-control solutions. The GCC is prioritizing specialty wound clinics, diabetes care, high-quality hospital infrastructure, and digital health adoption, creating opportunities for negative pressure wound therapy, skin substitutes, advanced hemostats, and structured digital wound documentation.

The European Union is defined by MDR conformity, sustainability expectations, antimicrobial stewardship, and rigorous clinical evidence requirements that favor products with demonstrable healing, safety, and economic benefits. BRICS countries offer scale, domestic manufacturing momentum, and broad chronic disease burden, but pricing, procurement, and access strategies must be localized to public and private healthcare realities. G7 markets continue to set evidence, reimbursement, quality, and post-market surveillance standards for advanced wound care. NATO-related demand reinforces innovation in trauma closure, hemorrhage control, burn care, infection prevention, and field-ready wound management technologies that can support military and civilian emergency care systems.

Key Country Insights

The United States leads in premium wound technologies, outpatient wound centers, home health integration, and value-based attention to surgical-site infection reduction, while Canada emphasizes evidence-based procurement, clinical guideline alignment, and equitable access across provinces. Mexico and Brazil show rising demand through private healthcare expansion, trauma care requirements, and increasing chronic wound needs linked to diabetes and vascular disease. The United Kingdom, Germany, France, Italy, and Spain are shaped by aging populations, public reimbursement scrutiny, antimicrobial stewardship, and demand for demonstrable cost offsets across hospitals, community care, and long-term care settings.

Russia requires localized supply, distributor reliability, and procurement resilience amid complex market access conditions. China and India represent high-volume opportunities driven by diabetes, surgery, hospital expansion, and government attention to healthcare infrastructure, while Japan and South Korea favor quality, innovation, infection control, and aging-care solutions for acute and chronic wounds. Australia combines strong clinical standards with remote-care needs, creating demand for telewound support, durable advanced dressings, and care models that can connect urban specialty providers with rural and remote patients.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize products that prove faster healing, fewer infections, fewer dressing changes, lower complication risk, and reduced total cost of care. Clinical evidence should include real-world outcomes across diabetic foot ulcers, venous leg ulcers, pressure injuries, burns, surgical wounds, and traumatic wounds, with endpoints that matter to clinicians, payers, and procurement teams, including time to closure, infection rates, pain, ease of use, and resource utilization.

Commercial teams should tailor portfolios by site of care: operating rooms require reliable closure, hemostasis, sealants, and surgical efficiency; wound centers require regenerative, antimicrobial, and exudate-management solutions; long-term care requires pressure injury prevention and simplified protocols; home care requires ease of use, patient adherence, and remote documentation. Leaders should also invest in AI-ready image capture, interoperable data systems, sustainable materials, antimicrobial stewardship, clinician training, and regional manufacturing or dual-sourcing to reduce supply risk.

Research Methodology

This executive summary is developed from a structured secondary-research methodology using validated public-health, regulatory, clinical, and economic sources. Inputs include WHO, United Nations, CDC, FDA, European Commission, OECD, International Diabetes Federation, peer-reviewed wound care literature, hospital quality frameworks, clinical guidelines, and publicly available reimbursement and regulatory disclosures.

The analysis triangulates disease burden, surgical demand, chronic wound risk factors, technology adoption, reimbursement trends, regulatory requirements, and regional healthcare infrastructure. Market interpretation emphasizes verified directional evidence over unsupported claims, with careful distinction between established clinical practice, emerging digital tools, and future innovation pathways. Conclusion

Wound closure and advanced wound care are moving from product-based purchasing to outcomes-based wound management. The strongest opportunities are linked to aging populations, diabetes-related complications, surgical recovery, infection prevention, home-based care, and technologies that make healing measurable across acute and chronic wound settings.

Organizations that combine clinical evidence, AI-enabled documentation, regional access strategies, clinician education, and resilient supply chains will be best positioned to serve providers and patients. As healthcare systems seek lower complication rates, fewer avoidable admissions, and better resource utilization, advanced wound care will remain a critical pillar of surgical quality, chronic disease management, trauma care, and value-based healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Wound Closure & Advanced Wound Care Market, by Product Type

  • 7.1. Traditional Wound Closure Devices
    • 7.1.1. Sutures
    • 7.1.2. Staples
    • 7.1.3. Mechanical Closure Devices
      • 7.1.3.1. Skin Closure Strips
      • 7.1.3.2. Zipper Closure Devices
      • 7.1.3.3. Retention Closure Devices
  • 7.2. Advanced Wound Dressings
    • 7.2.1. Foam Dressings
    • 7.2.2. Hydrogel Dressings
    • 7.2.3. Film Dressings
    • 7.2.4. Collagen Dressings
    • 7.2.5. Antimicrobial Dressings
  • 7.3. Hemostatic Agents And Sealants
  • 7.4. Advanced Therapies
    • 7.4.1. Negative Pressure Wound Therapy Devices
    • 7.4.2. Oxygen Therapy Systems
    • 7.4.3. Electrical Stimulation Devices
    • 7.4.4. Ultrasound Therapy Devices
  • 7.5. Biologics & Regenerative Products
    • 7.5.1. Skin Substitutes
      • 7.5.1.1. Allogeneic Skin Substitutes
      • 7.5.1.2. Xenogeneic Skin Substitutes
      • 7.5.1.3. Bioengineered Skin Substitutes
    • 7.5.2. Growth Factor Therapies
    • 7.5.3. Cell-Based Therapies

8. Wound Closure & Advanced Wound Care Market, by Wound Type

  • 8.1. Chronic Wounds
  • 8.2. Acute Wounds

9. Wound Closure & Advanced Wound Care Market, by Clinical Application

  • 9.1. Surgical Wound Closure
  • 9.2. Trauma Wound Management
  • 9.3. Sports Injury Management
  • 9.4. Reconstructive & Plastic Surgery
  • 9.5. Burn Wound Management
  • 9.6. Chronic Ulcer Management

10. Wound Closure & Advanced Wound Care Market, by Product Usability

  • 10.1. Single-Use
  • 10.2. Reusable

11. Wound Closure & Advanced Wound Care Market, by End User

  • 11.1. Hospitals
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Specialty Clinics
  • 11.4. Home Healthcare Providers
  • 11.5. Military & Veteran Care Facilities

12. Wound Closure & Advanced Wound Care Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Wound Closure & Advanced Wound Care Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Wound Closure & Advanced Wound Care Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Wound Closure & Advanced Wound Care Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Solventum Corporation
  • 17.2. Smith & Nephew PLC
  • 17.3. Molnlycke Health Care AB
  • 17.4. Baxter International Inc.
  • 17.5. Johnson & Johnson Services, Inc.
  • 17.6. Convatec Limited
  • 17.7. Paul Hartmann AG
  • 17.8. Organogenesis Inc.
  • 17.9. Medtronic PLC
  • 17.10. Coloplast A/S
  • 17.11. Medline Industries, Inc.
  • 17.12. Laboratoires Urgo
  • 17.13. Essity AB
  • 17.14. Integra LifeSciences Corporation
  • 17.15. MiMedx Group, Inc.
  • 17.16. Lohmann & Rauscher GmbH & Co. KG
  • 17.17. B. Braun SE
  • 17.18. Nichiban Co., Ltd.
  • 17.19. Zimmer Biomet Holdings, Inc.
  • 17.20. Cardinal Health, Inc.
  • 17.21. PolyNovo Limited
  • 17.22. Advanced Medical Solutions Group PLC
  • 17.23. Avery Dennison Corporation
  • 17.24. BDK Industrial Products Ltd.
  • 17.25. Biogennix, LLC
  • 17.26. DermaRite Industries, LLC
  • 17.27. Healogics, LLC
  • 17.28. Lotus Surgicals by TI Medical
  • 17.29. Plastod S.p.A

LIST OF FIGURES

  • FIGURE 1. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL TRADITIONAL WOUND CLOSURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL TRADITIONAL WOUND CLOSURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL TRADITIONAL WOUND CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SUTURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SUTURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SUTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STAPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STAPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STAPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MECHANICAL CLOSURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MECHANICAL CLOSURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MECHANICAL CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SKIN CLOSURE STRIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SKIN CLOSURE STRIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SKIN CLOSURE STRIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ZIPPER CLOSURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ZIPPER CLOSURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ZIPPER CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RETENTION CLOSURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RETENTION CLOSURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RETENTION CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ADVANCED WOUND DRESSINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ADVANCED WOUND DRESSINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ADVANCED WOUND DRESSINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FOAM DRESSINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FOAM DRESSINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FOAM DRESSINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HYDROGEL DRESSINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HYDROGEL DRESSINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HYDROGEL DRESSINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FILM DRESSINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FILM DRESSINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FILM DRESSINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COLLAGEN DRESSINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COLLAGEN DRESSINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COLLAGEN DRESSINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTIMICROBIAL DRESSINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANTIMICROBIAL DRESSINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTIMICROBIAL DRESSINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEMOSTATIC AGENTS AND SEALANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEMOSTATIC AGENTS AND SEALANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HEMOSTATIC AGENTS AND SEALANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ADVANCED THERAPIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ADVANCED THERAPIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ADVANCED THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OXYGEN THERAPY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OXYGEN THERAPY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OXYGEN THERAPY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ELECTRICAL STIMULATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ELECTRICAL STIMULATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ELECTRICAL STIMULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ULTRASOUND THERAPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ULTRASOUND THERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ULTRASOUND THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICS & REGENERATIVE PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICS & REGENERATIVE PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICS & REGENERATIVE PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SKIN SUBSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ALLOGENEIC SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ALLOGENEIC SKIN SUBSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ALLOGENEIC SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL XENOGENEIC SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL XENOGENEIC SKIN SUBSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL XENOGENEIC SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GROWTH FACTOR THERAPIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GROWTH FACTOR THERAPIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GROWTH FACTOR THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CELL-BASED THERAPIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CELL-BASED THERAPIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CELL-BASED THERAPIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CHRONIC WOUNDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CHRONIC WOUNDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CHRONIC WOUNDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ACUTE WOUNDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ACUTE WOUNDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ACUTE WOUNDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL WOUND CLOSURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL WOUND CLOSURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL WOUND CLOSURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TRAUMA WOUND MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL TRAUMA WOUND MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL TRAUMA WOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SPORTS INJURY MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SPORTS INJURY MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SPORTS INJURY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RECONSTRUCTIVE & PLASTIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL RECONSTRUCTIVE & PLASTIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL RECONSTRUCTIVE & PLASTIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BURN WOUND MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BURN WOUND MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BURN WOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CHRONIC ULCER MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CHRONIC ULCER MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CHRONIC ULCER MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SINGLE-USE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SINGLE-USE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SINGLE-USE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL REUSABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL REUSABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL REUSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HOME HEALTHCARE PROVIDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MILITARY & VETERAN CARE FACILITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MILITARY & VETERAN CARE FACILITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MILITARY & VETERAN CARE FACILITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 234. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 235. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 236. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 237. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 238. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 241. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. GCC WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 272. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 273. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 274. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 275. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 276. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 277. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 280. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. G7 WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 285. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 286. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 287. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 288. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 289. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 290. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 292. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 293. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 294. NATO WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 295. GLOBAL WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY SKIN SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY WOUND TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT USABILITY, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 309. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY TRADITIONAL WOUND CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 312. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY MECHANICAL CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 313. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED WOUND DRESSINGS, 2018-2032 (USD MILLION)
  • TABLE 314. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY ADVANCED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 315. CANADA WOUND CLOSURE & ADVANCED WOUND CARE MARKET SIZE, BY BIOLOGICS & REGENERATIVE PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 316. CANADA WOUN